Impulsivity, hyperactivity, and difficulty concentrating are some of the symptoms associated with attention deficit ...

Seoul National University Hospital researchers have linked childhood attention-deficit/hyperactivity disorder and ...

The MarketWatch News Department was not involved in the creation of this content.-- Centanafadine is an investigational compound for the treatment of ADHD in children, adolescents ...

Attention-Deficit Hyperactivity Disorder, or ADHD, affects tens of millions of people in the U.S.About one in nine children ...

Difficulty focusing isn’t always ADHD. Attention problems can stem from sleep, stress, mental health, or medical factors.

The FDA has started a priority review of Otsuka Pharma's triple-acting drug for attention-deficit hyperactivity disorder (ADHD), centanafadine, setting up a decision by 24th July.

Common eye conditions are linked to increased risks for incident attention-deficit/hyperactivity disorder, particularly in women and in the pediatric population, a retrospective study shows.

ADHD drugs don’t improve attention, new research finds – but they still work - More than seven million U.S. children and 15 million adults adults live with the lifelong brain disorder ...

Attention-deficit/hyperactivity disorder (ADHD) is a complex neurodevelopmental condition with a recognised genetic basis and significant clinical heterogeneity ...

From 2022 to 2024, stimulant prescriptions issued in Connecticut increased by 13.2 percent, according to data from the state.

Class of 2025 matriculant Kristin Basson shines, bagging three distinctions despite having severe ADHD and a learning ...